Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genocea Biosciences Inc (NASDAQ:GNCA)

6.00
Delayed Data
As of 4:00pm ET
 +0.17 / +2.92%
Today’s Change
3.28
Today|||52-Week Range
7.29
+45.63%
Year-to-Date
No recent news for Genocea Biosciences Inc.

Today’s Trading

Previous close5.83
Today’s open6.39
Day’s range5.93 - 6.78
Volume6,318,381
Average volume (3 months)343,153
Market cap$166.2M
Dividend yield--
Data as of 4:00pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)-0.57%
Earnings growth (this year)-9.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-64.93%
P/E ratioNM
Price/Sales496.14
Price/Book3.64

Competitors

 Today’s
change
Today’s
% change
XBITXBiotech Inc+0.17+3.63%
ENZYEnzymotec Ltd+0.70+9.86%
CGENCompugen Ltd+0.65+19.12%
ASTAsterias Biotherapeu...+0.05+1.39%
Data as of 6:30pm ET, 07/25/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$235.0K
Annual profit (last year)-$49.6M
Net profit margin-21,094.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Chip Clark
Chief Financial Officer &
Head-Investor Relations
Jonathan Michael Poole
Corporate headquarters
Cambridge, Massachusetts

Forecasts